Dr Reddy Signs a Deal with GlaxoSmithKline
Submitted by Anil Dayal on Wed, 03/30/2011 - 13:13
It has been confirmed that the Dr Reddy's Laboratories have been successful in attaining GlaxoSmithKline's US penicillin manufacturing facility and rights. The will be handling the Augmentin and Amoxil brands in the United States of America.
The Dr Reddy's Laboratories will only have the rights for the United States of America. GlaxoSmithKline will keep the rights for rest of the world.
Quetiapine from Dr. Reddy's Laboratories will be Fully Funded by Pharmac
Submitted by Tangaroa Snell on Mon, 08/30/2010 - 18:14
A drug funder of the New Zealand Government, Pharmac is ready to give funds to the Indian firm Dr. Reddy's Laboratories, which has made Quetiapine drug.
Pharmac has said that the subsidy for Seroquel, a brand of the antipsychotic drug Quetiapine will be reduced from 1 October and in its place they will introduce the new brand of Quetiapine made by the Indian pharma giant Dr. Reddy's Laboratories.
